Patients Discontinuing Anti-Obesity Injections Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

A recent study indicates that individuals who come off blockbuster slimming jabs like Mounjaro or Wegovy may regain shed pounds far faster than those who end traditional diet and exercise programs.

Findings released in a leading medical journal demonstrates that while obese people can lose a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month after stopping.

"Users purchasing these drugs must be informed of the danger of quick weight regain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.

This pace of regain suggests a reversion to starting mass within about a year and a half.

Weighing Approaches

The study, which looked at dozens of trials involving over 9,000 of participants, compared the outcomes of these new drugs with conventional dieting.

The team point out that people who lose weight through diet and exercise typically see a slower creep back—perhaps 100 grams monthly—post-intervention.

Explaining the Fast Regain

Doctors suggest the way of the injections is key to understanding the accelerated rebound.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Sustained high doses of GLP-1 levels far above than normal may cause the body to produce less of its endogenous GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this hormone supplement means hunger is no longer kept in check, making overeating a significant risk."

A Chronic Disease?

Health authorities recommend the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.

Many experts contend that, given the likelihood of relapse, the therapy should be considered life-long.

This view is supported by pharmaceutical companies, who note that the findings "emphasize the long-term nature of obesity," comparing it to managing conditions like hypertension.

User Experiences

Users who have stopped the jabs describe a intense resurgence of hunger.

"It was like a switch activating and you're instantly extremely hungry," recalled a patient.

This challenge is worsened if individuals have not adopted lasting lifestyle or habit changes during treatment.

Growing Use

Recent estimates show that millions of people in the UK have used these injections in the past year, with desire remaining high.

• Adoption is greater among females compared to males.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the medications through private healthcare rather than public health services.

In conclusion, experts stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent cure and long-term success hinges on ongoing behavioural support.